Clinical significance of telomerase activity in multiple myeloma
β Scribed by Motoaki Shiratsuchi; Koichiro Muta; Yasunobu Abe; Seiichi Motomura; Fumihiro Taguchi; Hiroshi Takatsuki; Naokuni Uike; Tsukuru Umemura; Hajime Nawata; Junji Nishimura
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 337 KB
- Volume
- 94
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We tested the significance of the Ki-67 plasma cell growth fraction in 49 bone marrow samples from 42 patients with multiple myeloma (MM). As a new approach to study myeloma cell proliferation, strong positivity of the CD38 antigen as plasma cell related feature was simultaneously evaluated with nuc
## Background: In this study, telomerase activity in human brain tumors was analyzed. ## Methods: Telomerase activity was examined in 41 brain tumor cases (20 of glioblastoma multiformes [gbms] [14 primary tumors and 6 recurrent tumors], 3 anaplastic astrocytomas [aas], 4 low grade astrocytomas [
Precise diagnosis of well-differentiated hepatocellular carcinoma (HCC) is sometimes difficult to establish. Telomerase activity was examined by telomeric-repeat-amplification protocol (TRAP) in 37 HCC nodules smaller than 3 cm in diameter, including 24 fine-needle-aspiration biopsy specimens, 22 no
The expression of the p 170 multidrug resistance protein by bone marrow plasma cells (BMPC) was assessed at clinical presentation in 53 patients with multiple myeloma (MM) using the C219 monoclonal antibody. Twenty-two of the 53 (41 per cent) patients had variable aliquots (1-60 per cent, median=6